Deep belly fat isnt just something we notice on the surface
Results and discussion Peptide-oligourea hybrids design and functional assay Our peptideoligourea hybrids design started with GLP-1-NH 2 and the introduction of a glycine in position 2 of GLP-1 instead of alanine (GLP-1-G 2 , 1 ) as it is known to prevent DPP-4 degradation 31,32,33
Sotyktu is the only tyrosine kinase 2 (TYK2) inhibitor to be approved for PsA To view or add a comment, sign in Key Updates in NICE 2026 Guidelines for Type 2 Diabetes The NICE 2026 guideline update (NG28) introduces an important shift in the initial drug management of Type 2 Diabetes, emphasizing early cardiometabolic protection and individualized therapy based on comorbidities
SGLT2i were initially approved for the treatment of type 2 diabetes in 2013 due to their glucose lowering effects
This suggests GLP-1 drugs may act earlier in the addiction cycle, reducing cue reactivity and craving, rather than reducing reward after use
I was nervous initially but once I spoke with Dr